| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.028 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |